Challenges and controversies in adrenal surgery: A practical approach.

[1]  A. Hakimi,et al.  Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature , 2023, Cancers.

[2]  A. Gill,et al.  Genotype–Phenotype Correlations and Clinical Outcomes in 155 Cases of Pheochromocytoma and Paraganglioma , 2022, World Journal of Surgery.

[3]  O. Shariq,et al.  Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension , 2022, World Journal of Surgery.

[4]  Jeffrey E. Lee,et al.  Pheochromocytoma recurrence in hereditary disease: does a cortical-sparing technique increase recurrence rate? , 2022, Surgery.

[5]  G. Materazzi,et al.  Surgical Management of Adrenocortical Carcinoma: A Literature Review , 2022, Journal of clinical medicine.

[6]  M. Rivera,et al.  Clinical course and imaging characteristics of benign adrenal cysts: a single-center study of 92 patients. , 2022, European journal of endocrinology.

[7]  Philip Smith,et al.  American Association of Endocrine Surgeons Guidelines for Adrenalectomy: Executive Summary. , 2022, JAMA surgery.

[8]  M. Walz,et al.  Tailored Approach in Adrenal Surgery: Retroperitoneoscopic Partial Adrenalectomy , 2022, Frontiers in Endocrinology.

[9]  E. Baudin,et al.  First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study. , 2022, Journal of Clinical Oncology.

[10]  Y. Pommier,et al.  New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications , 2022, Cancers.

[11]  D. Fraker,et al.  Survival After Adrenalectomy for Metastatic Lung Cancer , 2022, Annals of Surgical Oncology.

[12]  A. Tabarin,et al.  Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors , 2022, Annals of Internal Medicine.

[13]  Mark W. Ball,et al.  Partial versus total adrenalectomy for pheochromocytoma: a population-based comparison of outcomes , 2021, International Urology and Nephrology.

[14]  I. Poon,et al.  Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study , 2021, Clinical and translational radiation oncology.

[15]  V. Livolsi,et al.  A Cyst-ematic Analysis of the Adrenal Gland. , 2021, American journal of clinical pathology.

[16]  D. McAneny,et al.  Incidental Adrenal Masses: Adherence to Guidelines and Methods to Improve Initial Follow-Up, A Systematic Review. , 2021, The Journal of surgical research.

[17]  A. Shaaban,et al.  Adrenal hemorrhage and hemorrhagic masses; diagnostic workup and imaging findings. , 2021, The British journal of radiology.

[18]  Jan Calissendorff,et al.  Adrenal myelolipomas. , 2021, The lancet. Diabetes & endocrinology.

[19]  D. Leszczyńska,et al.  Adrenal "nonadenoma" - clinical characteristic and risk of malignancy. , 2021, Endokrynologia Polska.

[20]  M. Löndahl,et al.  Association Between Mortality and Levels of Autonomous Cortisol Secretion by Adrenal Incidentalomas , 2021, Annals of Internal Medicine.

[21]  P. White,et al.  Congenital adrenal hyperplasia - current insights in pathophysiology, diagnostics and management. , 2021, Endocrine reviews.

[22]  K. Nanba,et al.  Genetics in Endocrinology: Impact of race and sex on genetic causes of aldosterone-producing adenomas. , 2021, European journal of endocrinology.

[23]  K. Quencer.  Adrenal vein sampling: technique and protocol, a systematic review , 2021, CVIR Endovascular.

[24]  S. Theocharis,et al.  Tumor Microenvironment in Adrenocortical Carcinoma: Barrier to Immunotherapy Success? , 2021, Cancers.

[25]  C. Kornhuber,et al.  Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis , 2021, International journal of cancer.

[26]  J. Bertherat,et al.  Update on primary bilateral macronodular adrenal hyperplasia (PBMAH) , 2021, Endocrine.

[27]  E. Caoili,et al.  18F-FDG-PET/CT Evaluation of Indeterminate Adrenal Masses in Non-Cancer Patients. , 2021, The Journal of clinical endocrinology and metabolism.

[28]  T. Fahey,et al.  Association of Adrenal Venous Sampling With Outcomes in Primary Aldosteronism for Unilateral Adenomas. , 2020, JAMA surgery.

[29]  A. Levine,et al.  American Association of Clinical Endocrinology Disease State Clinical Review on the Evaluation and Management of Adrenocortical Carcinoma in an Adult: a Practical Approach. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[30]  W. Young,et al.  Epidemiology of adrenal tumours in Olmsted County, Minnesota, USA: a population-based cohort study. , 2020, The lancet. Diabetes & endocrinology.

[31]  I. Bancos,et al.  Presentation, disease progression and outcomes of adrenal gland metastases , 2020, Clinical endocrinology.

[32]  D. Fraker,et al.  Adrenalectomy for Secondary Malignancy: Patients, Outcomes, and Indications , 2020, Annals of surgery.

[33]  W. Young,et al.  Clinical course of adrenal myelolipoma: A long‐term longitudinal follow‐up study , 2020, Clinical endocrinology.

[34]  Xiang Li,et al.  Minimally Invasive Versus Open Adrenalectomy in Patients with Adrenocortical Carcinoma: A Meta-analysis , 2020, Annals of Surgical Oncology.

[35]  J. Phay,et al.  Update on Pheochromocytoma and Paraganglioma from the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma , 2020, Annals of Surgical Oncology.

[36]  M. Berger,et al.  PD-1 Blockade in Advanced Adrenocortical Carcinoma. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  G. Rossi.  Primary Aldosteronism: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[38]  R. Auchus,et al.  Three Discrete Patterns of Primary Aldosteronism Lateralization in Response to Cosyntropin during Adrenal Vein Sampling. , 2019, The Journal of clinical endocrinology and metabolism.

[39]  D. Delivanis,et al.  Modern Management of Mild Autonomous Cortisol Secretion , 2019, Clinical pharmacology and therapeutics.

[40]  H. Timmers,et al.  Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial , 2019, The Journal of clinical endocrinology and metabolism.

[41]  T. Yanase,et al.  A nationwide survey of adrenal incidentalomas in Japan: the first report of clinical and epidemiological features. , 2019, Endocrine journal.

[42]  Jeffrey E. Lee,et al.  Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma , 2019, Journal of Immunotherapy for Cancer.

[43]  S. Jolly,et al.  Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma. , 2019, The Journal of clinical endocrinology and metabolism.

[44]  J. Funder.  Primary Aldosteronism. , 2019, Hypertension.

[45]  W. Young,et al.  Comparison of Pheochromocytoma-Specific Morbidity and Mortality Among Adults With Bilateral Pheochromocytomas Undergoing Total Adrenalectomy vs Cortical-Sparing Adrenalectomy , 2019, JAMA network open.

[46]  M. Kris,et al.  Adrenal Metastasectomy in the Presence and Absence of Extraadrenal Metastatic Disease. , 2019, Annals of surgery.

[47]  A. Charalampopoulos,et al.  Pheochromocytoma , 2019, Endocrine regulations.

[48]  K. Pacak,et al.  Postoperative Management in Patients with Pheochromocytoma and Paraganglioma , 2019, Cancers.

[49]  Fares Alahdab,et al.  Natural History of Adrenal Incidentalomas With and Without Mild Autonomous Cortisol Excess , 2019, Annals of Internal Medicine.

[50]  A. Bilchik,et al.  Impact of Effective Systemic Therapy on Metastasectomy in Stage IV Melanoma: A Matched-Pair Analysis , 2019, Annals of Surgical Oncology.

[51]  M. Sone,et al.  Lateralizing Asymmetry of Adrenal Imaging and Adrenal Vein Sampling in Patients With Primary Aldosteronism , 2019, Journal of the Endocrine Society.

[52]  Q. Duh,et al.  Laparoscopic adrenalectomy for metastatic disease: Retrospective cohort with long‐term, comprehensive follow‐up , 2019, Surgery.

[53]  M. Ruchała,et al.  Malignancy Risk and Hormonal Activity of Adrenal Incidentalomas in a Large Cohort of Patients from a Single Tertiary Reference Center , 2019, International journal of environmental research and public health.

[54]  Mark W. Ball,et al.  MP69-07 LONG-TERM FUNCTIONAL AND ONCOLOGIC OUTCOMES OF PARTIAL ADRENALECTOMY FOR PHEOCHROMOCYTOMA , 2019, Urology.

[55]  C. Nies,et al.  Surgical therapy of adrenal tumors: guidelines from the German Association of Endocrine Surgeons (CAEK) , 2019, Langenbeck's archives of surgery.

[56]  J. Malcolm,et al.  Cardiovascular Outcomes in Autonomous Cortisol Secretion and Nonfunctioning Adrenal Adenoma: A Systematic Review , 2019, Journal of the Endocrine Society.

[57]  C. Georgiades,et al.  Adrenal vein sampling with and without cosyntropin stimulation for detection of surgically remediable aldosteronism , 2019, Endocrinology, diabetes & metabolism.

[58]  P. O’Dwyer,et al.  Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[59]  Eric Baudin,et al.  European Society of Endocrinology Clinical Practice Guidelines on the Management of Adrenocortical Carcinoma in Adults, in collaboration with the European Network for the Study of Adrenal Tumors. , 2018, European journal of endocrinology.

[60]  C. Solórzano,et al.  Evaluation, Staging, and Surgical Management for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group , 2018, Annals of Surgical Oncology.

[61]  C. Solórzano,et al.  Adjuvant and Neoadjuvant Therapy, Treatment for Advanced Disease, and Genetic Considerations for Adrenocortical Carcinoma: An Update from the SSO Endocrine and Head and Neck Disease Site Working Group , 2018, Annals of Surgical Oncology.

[62]  M. Laniado,et al.  Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis , 2018, European Radiology.

[63]  B. Amgai,et al.  The Characteristics and Trends in Adrenocortical Carcinoma: A United States Population Based Study , 2018, Journal of clinical medicine research.

[64]  D. Nelson,et al.  Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma , 2018, Annals of Surgical Oncology.

[65]  C. Zoccali,et al.  Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term , 2018, Hypertension.

[66]  R. Auchus,et al.  Refining the Definitions of Biochemical and Clinical Cure for Primary Aldosteronism Using the Primary Aldosteronism Surgical Outcome (PASO) Classification System , 2018, World Journal of Surgery.

[67]  T. Pawlik,et al.  Laparoscopic Versus Open Adrenalectomy for Localized/Locally Advanced Primary Adrenocortical Carcinoma (ENSAT I-III) in Adults: Is Margin-Free Resection the Key Surgical Factor that Dictates Outcome? A Review of the Literature. , 2018, Journal of laparoendoscopic & advanced surgical techniques. Part A.

[68]  W. Young,et al.  Diagnostic performance of unenhanced computed tomography and 18F‐fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours , 2018, Clinical endocrinology.

[69]  W. Young,et al.  Clinical, Biochemical, and Radiological Characteristics of a Single-Center Retrospective Cohort of 705 Large Adrenal Tumors , 2017, Mayo Clinic proceedings. Innovations, quality & outcomes.

[70]  J. Bertherat,et al.  Genetics of tumors of the adrenal cortex. , 2017, Endocrine-related cancer.

[71]  James Brian Byrd,et al.  Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism , 2017, Clinical endocrinology.

[72]  D. Daye,et al.  Local Control and Survival after Image-Guided Percutaneous Ablation of Adrenal Metastases. , 2017, Journal of vascular and interventional radiology : JVIR.

[73]  L. Thanos,et al.  Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience , 2017, Chinese medical journal.

[74]  W. Young,et al.  Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. , 2017, The lancet. Diabetes & endocrinology.

[75]  G. Israel,et al.  Management of Incidental Adrenal Masses: A White Paper of the ACR Incidental Findings Committee. , 2017, Journal of the American College of Radiology : JACR.

[76]  B. Åsvold,et al.  Simultaneous assay of cortisol and dexamethasone improved diagnostic accuracy of the dexamethasone suppression test. , 2017, European journal of endocrinology.

[77]  T. Else,et al.  PERSONALIZED CARE OF PATIENTS WITH ADRENOCORTICAL CARCINOMA: A COMPREHENSIVE APPROACH. , 2017, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[78]  F. Veglio,et al.  Prevalence and Clinical Manifestations of Primary Aldosteronism Encountered in Primary Care Practice. , 2017, Journal of the American College of Cardiology.

[79]  G. Tiberio,et al.  Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma , 2017, The Journal of clinical endocrinology and metabolism.

[80]  A. Lowery,et al.  Posterior retroperitoneoscopic adrenal surgery for clinical and subclinical Cushing’s syndrome in patients with bilateral adrenal disease , 2017, Langenbeck's Archives of Surgery.

[81]  H. Neumann,et al.  Perioperative &agr;-receptor blockade in phaeochromocytoma surgery: an observational case series† , 2017, British journal of anaesthesia.

[82]  Antonio L Amelio,et al.  Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma. , 2017, Cancer cell.

[83]  David F. Schneider,et al.  Minimally Invasive Resection of Adrenocortical Carcinoma: a Multi-Institutional Study of 201 Patients , 2017, Journal of Gastrointestinal Surgery.

[84]  M. Bufi,et al.  Clinical Benefits of Unilateral Adrenalectomy in Patients with Subclinical Hypercortisolism Due to Adrenal Incidentaloma: Results from a Single Center , 2017, High Blood Pressure & Cardiovascular Prevention.

[85]  R. Ramachandran,et al.  Current perioperative management of pheochromocytomas , 2017, Indian journal of urology : IJU : journal of the Urological Society of India.

[86]  Fares Alahdab,et al.  THERAPY OF ENDOCRINE DISEASE: Improvement of cardiovascular risk factors after adrenalectomy in patients with adrenal tumors and subclinical Cushing's syndrome: a systematic review and meta-analysis. , 2016, European journal of endocrinology.

[87]  J. Sicklick,et al.  Clinical Score Predicting Long-Term Survival after Repeat Resection for Recurrent Adrenocortical Carcinoma. , 2016, Journal of the American College of Surgeons.

[88]  Devin C. Flaherty,et al.  Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma. , 2016, Journal of the American College of Surgeons.

[89]  W. Arlt,et al.  Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis , 2016 .

[90]  Fares Alahdab,et al.  DIAGNOSIS OF ENDOCRINE DISEASE: The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis. , 2016, European journal of endocrinology.

[91]  A. Tabarin,et al.  Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. , 2016, European journal of endocrinology.

[92]  Benjamin J Raphael,et al.  Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma. , 2016, Cancer cell.

[93]  W. Young,et al.  The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. , 2016, The Journal of clinical endocrinology and metabolism.

[94]  I. Chiodini,et al.  Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism. , 2016, European journal of endocrinology.

[95]  S. Tsagarakis,et al.  Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas. , 2015, European journal of endocrinology.

[96]  A. Tabarin,et al.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. , 2015, The Journal of clinical endocrinology and metabolism.

[97]  H. Sasano,et al.  Adrenocortical carcinoma: review of the pathologic features, production of adrenal steroids, and molecular pathogenesis. , 2015, Endocrinology and metabolism clinics of North America.

[98]  A. Vaidya,et al.  Cortisol dysregulation in obesity-related metabolic disorders , 2015, Current opinion in endocrinology, diabetes, and obesity.

[99]  Afshin Gangi,et al.  Thermal ablation of colorectal liver metastases: a position paper by an international panel of ablation experts, the interventional oncology sans frontières meeting 2013 , 2015, European Radiology.

[100]  Su Lim Lee,et al.  Laparoscopic hand-assisted adrenal sparing surgery for a giant adrenal myelolipoma: A case report. , 2015, International surgery.

[101]  G. Eslick,et al.  Recurrence and functional outcomes of partial adrenalectomy: a systematic review and meta-analysis. , 2015, International journal of surgery.

[102]  D. Fraker,et al.  The rise in metastasectomy across cancer types over the past decade , 2015, Cancer.

[103]  D. Nitti,et al.  Systematic review of surgical treatment of subclinical Cushing's syndrome , 2015, The British journal of surgery.

[104]  R. Rosenthal,et al.  Technical description and feasibility of laparoscopic adrenal contouring using fluorescence imaging , 2015, Surgical Endoscopy.

[105]  M. Bradburn,et al.  Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. , 2014, The Journal of clinical endocrinology and metabolism.

[106]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[107]  G. Doherty,et al.  Surgical management of adrenocortical tumours , 2014, Nature Reviews Endocrinology.

[108]  D. Nichols,et al.  A single-institution experience in image-guided thermal ablation of adrenal gland metastases. , 2014, Journal of vascular and interventional radiology : JVIR.

[109]  Jeffrey E. Lee,et al.  Borderline Resectable Adrenal Cortical Carcinoma: A Potential Role for Preoperative Chemotherapy , 2014, World Journal of Surgery.

[110]  A. Tavakkoli,et al.  Laparoscopic adrenal metastasectomy: appropriate, safe, and feasible , 2014, Surgical Endoscopy.

[111]  L. Du,et al.  Predictors of Hemodynamic Instability During Surgery for Pheochromocytoma , 2014, Annals of Surgical Oncology.

[112]  Jeffrey E. Lee,et al.  Adrenal Metastectomy is Safe in Selected Patients , 2014, World Journal of Surgery.

[113]  C. Wood,et al.  Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. , 2013, European journal of endocrinology.

[114]  K. Lorenz,et al.  Adrenalectomy for solid tumor metastases: results of a multicenter European study. , 2013, Surgery.

[115]  F. Mazzariol,et al.  Adrenal cysts: natural history by long-term imaging follow-up. , 2013, AJR. American journal of roentgenology.

[116]  Daniel T. Holmes,et al.  Adrenal vein sampling: substantial need for technical improvement at regional referral centres. , 2013, Clinical biochemistry.

[117]  R. Fanelli,et al.  SAGES guidelines for minimally invasive treatment of adrenal pathology , 2013, Surgical Endoscopy.

[118]  F. Deng,et al.  Cystic lesions of the adrenal gland: our experience over the last 20 years. , 2013, Human pathology.

[119]  Mi-Yeon Kim,et al.  Utilisation of combined 18F-FDG PET/CT scan for differential diagnosis between benign and malignant adrenal enlargement. , 2013, The British journal of radiology.

[120]  L. Yip,et al.  Outcome and Prognostic Factors After Adrenalectomy for Patients with Distant Adrenal Metastasis , 2013, Annals of Surgical Oncology.

[121]  Jeffrey E. Lee,et al.  Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? , 2013, Surgical Endoscopy.

[122]  Sara C. Fallon,et al.  The utility of cortical-sparing adrenalectomy in pheochromocytomas associated with genetic syndromes. , 2013, Journal of pediatric surgery.

[123]  L. Fishbein,et al.  Pheochromocytoma/Paraganglioma: Review of Perioperative Management of Blood Pressure and Update on Genetic Mutations Associated With Pheochromocytoma , 2013, Journal of clinical hypertension.

[124]  A. Crispin,et al.  Prolonged overall survival after pulmonary metastasectomy in patients with breast cancer. , 2013, The Annals of thoracic surgery.

[125]  C. Stratakis,et al.  Adrenal Histologic Findings Show No Difference in Clinical Presentation and Outcome in Primary Hyperaldosteronism , 2013, Annals of Surgical Oncology.

[126]  Jeffrey E. Lee,et al.  Long-term outcomes of surgical treatment for hereditary pheochromocytoma. , 2013, Journal of the American College of Surgeons.

[127]  G. Hammer,et al.  Resection of adrenocortical carcinoma is less complete and local recurrence occurs sooner and more often after laparoscopic adrenalectomy than after open adrenalectomy. , 2012, Surgery.

[128]  M. Morino,et al.  Open versus endoscopic adrenalectomy in the treatment of localized (stage I/II) adrenocortical carcinoma: results of a multiinstitutional Italian survey. , 2012, Surgery.

[129]  A. Fassina,et al.  Unilateral adrenal hyperplasia: a novel cause of surgically correctable primary hyperaldosteronism. , 2012, Surgery.

[130]  S. Roman,et al.  A cost-effectiveness analysis of adrenalectomy for nonfunctional adrenal incidentalomas: is there a size threshold for resection? , 2012, Surgery.

[131]  W. Linehan,et al.  Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome. , 2012, Journal of pediatric surgery.

[132]  M. Brennan,et al.  Recommendation for standardized surgical management of primary adrenocortical carcinoma. , 2012, Surgery.

[133]  C. Schade-Brittinger,et al.  Combination chemotherapy in advanced adrenocortical carcinoma. , 2012, The New England journal of medicine.

[134]  C. Lohse,et al.  Adrenalectomy Improves Outcomes of Selected Patients with Metastatic Carcinoma , 2012, World Journal of Surgery.

[135]  S. Trerotola,et al.  The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism. , 2012, The Journal of clinical endocrinology and metabolism.

[136]  J. Peix,et al.  Positional statement of the European Society of Endocrine Surgeons (ESES) on malignant adrenal tumors , 2012, Langenbeck's Archives of Surgery.

[137]  G. Muscogiuri,et al.  Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: A multicenter longitudinal study , 2011, Journal of Bone and Mineral Research.

[138]  D. Farley,et al.  Primary aldosteronism: results of adrenalectomy for nonsingle adenoma. , 2011, Journal of the American College of Surgeons.

[139]  F. Beuschlein,et al.  Adrenal Venous Sampling: Evaluation of the German Conn's Registry , 2011, Hypertension.

[140]  T. Chua,et al.  Progression and survival results after radical hepatic metastasectomy of indolent advanced neuroendocrine neoplasms (NENs) supports an aggressive surgical approach. , 2011, Surgery.

[141]  A. Agha,et al.  Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers. , 2010, The Journal of clinical endocrinology and metabolism.

[142]  G. Thompson,et al.  Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. , 2010, Urology.

[143]  Weiqing Wang,et al.  Selective α1-adrenoceptor antagonist (controlled release tablets) in preoperative management of pheochromocytoma , 2010, Endocrine.

[144]  C. Fiori,et al.  Retrospective evaluation of the outcome of open versus laparoscopic adrenalectomy for stage I and II adrenocortical cancer. , 2010, European urology.

[145]  G. Hammer,et al.  Laparoscopic Resection is Inappropriate in Patients with Known or Suspected Adrenocortical Carcinoma , 2010, World Journal of Surgery.

[146]  S. Roman,et al.  Outcomes from 3144 adrenalectomies in the United States: which matters more, surgeon volume or specialty? , 2009, Archives of surgery.

[147]  L. S. Schultze Kool,et al.  Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism , 2009, Annals of Internal Medicine.

[148]  Q. Duh,et al.  American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[149]  A. Toniato,et al.  Surgical Versus Conservative Management for Subclinical Cushing Syndrome in Adrenal Incidentalomas: A Prospective Randomized Study , 2009, Annals of surgery.

[150]  G. Hammer,et al.  The role of radiologic studies in the evaluation and management of primary hyperaldosteronism. , 2008, Surgery.

[151]  D. Bentrem,et al.  Adrenocortical carcinoma in the United States , 2008, Cancer.

[152]  William W Mayo-Smith,et al.  The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. , 2008, AJR. American journal of roentgenology.

[153]  P. Carpenter,et al.  The Clinical Conundrum of Corticotropin-independent Autonomous Cortisol Secretion in Patients with Bilateral Adrenal Masses , 2008, World Journal of Surgery.

[154]  F. Veglio,et al.  Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. , 2008, The Journal of clinical endocrinology and metabolism.

[155]  D. Farley,et al.  The Aldosteronoma Resolution Score: Predicting Complete Resolution of Hypertension After Adrenalectomy for Aldosteronoma , 2008, Annals of surgery.

[156]  G. Bepler,et al.  Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[157]  Jeffrey E. Lee,et al.  Response to mitotane predicts outcome in patients with recurrent adrenal cortical carcinoma. , 2007, Surgery.

[158]  K. Pacak.  Preoperative management of the pheochromocytoma patient. , 2007, The Journal of clinical endocrinology and metabolism.

[159]  Yuman Fong,et al.  Actual 10-year survival after resection of colorectal liver metastases defines cure. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[160]  Laura H. Tang,et al.  Laparoscopic Adrenalectomy for Isolated Adrenal Metastasis , 2007, Annals of Surgical Oncology.

[161]  Herb Chen,et al.  Equal oncologic results for laparoscopic and open resection of adrenal metastases. , 2007, The Journal of surgical research.

[162]  M. Papotti,et al.  Adjuvant mitotane treatment for adrenocortical carcinoma. , 2007, The New England journal of medicine.

[163]  E. Porteri,et al.  A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. , 2006, Journal of the American College of Cardiology.

[164]  B. Wolffenbuttel,et al.  Preoperative pharmacological management of phaeochromocytoma. , 2006, The Netherlands journal of medicine.

[165]  Martin Fassnacht,et al.  Adrenocortical Carcinoma: Clinical Update , 2006 .

[166]  Q. Duh,et al.  Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone-producing Adenomas , 2006, World Journal of Surgery.

[167]  G. Lebuffe,et al.  The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas , 2005, Anaesthesia.

[168]  P. Milliez,et al.  Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. , 2005, Journal of the American College of Cardiology.

[169]  W. Young,et al.  Role for adrenal venous sampling in primary aldosteronism. , 2004, Surgery.

[170]  R. Hartman,et al.  Cystic adrenal neoplasms , 2004, Cancer.

[171]  O. Mundler,et al.  Does iodine‐131 meta‐iodobenzylguanidine (MIBG) scintigraphy have an impact on the management of sporadic and familial phaeochromocytoma? , 2004, Clinical endocrinology.

[172]  W. Young,et al.  Increased Diagnosis of Primary Aldosteronism, Including Surgically Correctable Forms, in Centers from Five Continents , 2004 .

[173]  T. Zelinka,et al.  Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region , 2003, Journal of Human Hypertension.

[174]  S. Koçak,et al.  Alpha blockade in preoperative preparation of patients with pheochromocytomas. , 2002, International surgery.

[175]  J. Farndon,et al.  Efficacy and Safety of Doxazosin for Perioperative Management of Patients with Pheochromocytoma , 2002, World Journal of Surgery.

[176]  M. Walther,et al.  Biochemical diagnosis of pheochromocytoma: which test is best? , 2002, JAMA.

[177]  K. Lam,et al.  Metastatic tumours of the adrenal glands: a 30‐year experience in a teaching hospital , 2002, Clinical endocrinology.

[178]  E. Baudin,et al.  Impact of monitoring plasma 1,1‐dichlorodiphenildichloroethane (o,p′DDD) levels on the treatment of patients with adrenocortical carcinoma , 2001, Cancer.

[179]  M. Brennan,et al.  Long-Term Survival After Complete Resection and Repeat Resection in Patients With Adrenocortical Carcinoma , 1999, Annals of Surgical Oncology.

[180]  F. Nance,et al.  Management of Adrenal Cysts , 1999, The American surgeon.

[181]  J. Abbruzzese,et al.  Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. , 1998, Surgery.

[182]  W. J. Russell,et al.  The Preoperative Management of Phaeochromocytoma , 1998, Anaesthesia and intensive care.

[183]  J. Luketich,et al.  Does resection of adrenal metastases from non-small cell lung cancer improve survival? , 1996, The Annals of thoracic surgery.

[184]  E. Kazerooni,et al.  Percutaneous CT‐Guided Biopsy of Adrenal Masses: Immediate and Delayed Complications , 1995, Journal of computer assisted tomography.

[185]  G. Fleuren,et al.  Optimal treatment of adrenocortical carcinoma with mitotane: results in a consecutive series of 96 patients. , 1994, British Journal of Cancer.

[186]  G. Krestin,et al.  Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[187]  M. Gross,et al.  Sub-clinical Cushing's syndrome in patients with adrenal gland incidentalomas. Pitfalls in diagnosis and management. , 1990, The American surgeon.

[188]  L. Kurland,et al.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. , 1983, Mayo Clinic proceedings.

[189]  M. Tidd,et al.  Hyperaldosteronism , 2007, Acta Chirurgica Austriaca.

[190]  T. Matsuda,et al.  Efficacy and safety of metyrosine in pheochromocytoma/paraganglioma: a multi-center trial in Japan. , 2018, Endocrine journal.

[191]  P. Igaz,et al.  Adrenal myelolipoma: a comprehensive review , 2017, Endocrine.

[192]  F. Pattou,et al.  Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study , 2017, Surgery.

[193]  C. Lombardi,et al.  Outcome of adrenalectomy for subclinical hypercortisolism and Cushing syndrome , 2017, Surgery.

[194]  H. Neumann,et al.  MANAGEMENT OF ENDOCRINE DISEASE: Outcome of adrenal sparing surgery in heritable pheochromocytoma. , 2016, European journal of endocrinology.

[195]  Intraoperative use of Indocyanine Green to Confirm Perfusion of Remnant Tissue in Cortical-Sparing Retroperitoneoscopic Adrenalectomy , 2016 .

[196]  Z. Gaciong,et al.  Laparoscopic treatment of adrenal cysts--own research and literature review. , 2015, Endokrynologia Polska.

[197]  G. Cavallaro,et al.  Cystic adrenal lesions: clinical and surgical management. The experience of a referral centre. , 2015, International journal of surgery.

[198]  S. Jolly,et al.  Adrenocortical Carcinoma , 2010, Cancers.

[199]  F. Beuschlein,et al.  The role of surgery in the management of recurrent adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[200]  Jeffrey E. Lee,et al.  A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma. , 2013, The Journal of clinical endocrinology and metabolism.

[201]  Q. Duh,et al.  Sporadic Paraganglioma , 2007, World Journal of Surgery.

[202]  J. A. Alonso Dorrego,et al.  [Spontaneous retroperitoneal hematoma secondary to the rupture of suprarenal myelolipoma]. , 2000, Archivos espanoles de urologia.

[203]  H. Black,et al.  A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience. , 1991, Medicine.